Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Tuesday, June 02, 2015 2:59:40 PM
bullish
## source: finance.yahoo.com
Mon, 01 Jun 2015 15:44:01 GMT ~ Seattle Genetics Highlights ADCETRIS® (Brentuximab Vedotin) Data Presentations in the AETHERA Post-Transplant Consolidation Setting and in Frontline DLBCL at ASCO Annual Meeting
[at noodls] - CHICAGO--(BUSINESS WIRE)--Jun. 1, 2015-- Seattle Genetics, Inc. (Nasdaq: SGEN) today announced several ADCETRIS (brentuximab vedotin) data presentations in the AETHERA post-transplant consolidation setting ...
read full: http://www.noodls.com/view/8A041653E63633EAED7FC22A1AF995D15F502AD1
*********************************************************
Mon, 01 Jun 2015 14:46:00 GMT ~ 10:46 am Seattle Genetics announces Adcetris data presentations, in the AETHERA post-transplant consolidation setting for Hodgkin lymphoma, and in frontline diffuse large B-cell lymphoma
read full: http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#sgen
*********************************************************
Mon, 01 Jun 2015 14:45:00 GMT ~ Seattle Genetics Highlights ADCETRIS® (Brentuximab Vedotin) Data Presentations in the AETHERA Post-Transplant Consolidation Setting and in Frontline DLBCL at ASCO Annual Meeting
[Business Wire] - Seattle Genetics, Inc. today announced several ADCETRIS data presentations in the AETHERA post-transplant consolidation setting for Hodgkin lymphoma and in frontline diffuse large B-cell lymphoma at the American Society of Clinical Oncology 50th Annual Meeting being held May 29 to June 2, 2015, in Chicago, IL.
read full: http://finance.yahoo.com/news/seattle-genetics-highlights-adcetris-brentuximab-144500733.html
*********************************************************
Thu, 28 May 2015 13:46:11 GMT ~ Seattle Genetics Announces Clinical Data Presentations from Multiple Antibody-Drug Conjugate (ADC) Programs at ASCO Annual Meeting
[at noodls] - BOTHELL, Wash.--(BUSINESS WIRE)--May 28, 2015-- Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that data from multiple proprietary and collaborator antibody-drug conjugate (ADC) programs will be ...
read full: http://www.noodls.com/view/8ADD42EF697AF6435C3F1BFD4DB198DBD36A526B
*********************************************************
Thu, 28 May 2015 13:00:00 GMT ~ Seattle Genetics Announces Clinical Data Presentations from Multiple Antibody-Drug Conjugate (ADC) Programs at ASCO Annual Meeting
[Business Wire] - Seattle Genetics, Inc. today announced that data from multiple proprietary and collaborator antibody-drug conjugate programs will be highlighted in more than 10 sessions at the American Society of Clinical Oncology 2015 Annual Meeting being held May 29 to June 2, 2015 in Chicago, IL.
read full: http://finance.yahoo.com/news/seattle-genetics-announces-clinical-data-130000628.html
*********************************************************
$SGEN charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$SGEN company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/SGEN/company-info
Ticker: $SGEN
OTC Market Place: Not Available
CIK code: 0001060736
Company name: Seattle Genetics, Inc.
Company website: http://www.seattlegenetics.com
Incorporated In: DE, USA
$SGEN share structure
## source: otcmarkets.com
Market Value: $5,418,840,899 a/o Jun 01, 2015
Shares Outstanding: 124,886,861 a/o Apr 28, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$SGEN extra dd links
Company name: Seattle Genetics, Inc.
Company website: http://www.seattlegenetics.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/SGEN/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/SGEN/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=SGEN+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=SGEN+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=SGEN+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/SGEN/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/SGEN/news - http://finance.yahoo.com/q/h?s=SGEN+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/SGEN/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/SGEN/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/SGEN/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/SGEN/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/SGEN/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/SGEN/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/SGEN/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/SGEN/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=SGEN+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/SGEN
DTCC (dtcc.com): http://search2.dtcc.com/?q=Seattle+Genetics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Seattle+Genetics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Seattle+Genetics%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.seattlegenetics.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.seattlegenetics.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.seattlegenetics.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/SGEN/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/SGEN
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/SGEN/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/SGEN/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/SGEN/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001060736&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/SGEN/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/SGEN/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/SGEN/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/SGEN/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=SGEN&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=SGEN
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/SGEN/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=SGEN+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=SGEN+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=SGEN
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=SGEN
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=SGEN+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/SGEN/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=SGEN+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/SGEN.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=SGEN
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/SGEN/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/SGEN/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/SGEN/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/SGEN/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/SGEN
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/SGEN
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/SGEN:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=SGEN
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=SGEN
$SGEN DD Notes ~ http://www.ddnotesmaker.com/SGEN
Recent SGEN News
- Wall Street Highlights: HPE and Juniper Networks in Negotiations, Elliott Invests $1 Billion in Match Group, and More • IH Market News • 01/09/2024 11:12:25 AM
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 12/26/2023 11:12:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2023 11:46:48 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 12/18/2023 10:25:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:55:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:46:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:42:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:39:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:38:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:32:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:31:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:29:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:24:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:16:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:16:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:10:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:10:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:05:42 PM
- PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) Approved by FDA as the First and Only ADC Plus PD-1 to Treat Advanced Bladder Cancer • PR Newswire (US) • 12/15/2023 10:00:00 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 12/14/2023 01:47:48 PM
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM